Wynzora Cream
Product Images NDC 73499-001

4 FDA label images from Mc2 Therapeutics Ltd · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Wynzora (NDC 73499-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mc2 Therapeutics Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Wynzora 01)

Chemical Structure (Wynzora 01)
Chemical structure of calcipotriene, the active ingredient in Wynzora cream. The diagram shows the molecular arrangement of calcipotriene, a vitamin D analog used topically.*
FDA Label Image

Chemical Structure (Wynzora 02)

Chemical Structure (Wynzora 02)
Chemical structure of betamethasone dipropionate, an active ingredient in Wynzora cream containing calcipotriene and betamethasone dipropionate for topical use.*
FDA Label Image

Principal Display Panel (60 g Tube Carton)

Principal Display Panel (60 g Tube Carton)
Wynzora cream packaging label features the proprietary name Wynzora with active ingredients calcipotriene and betamethasone dipropionate. It is a topical cream with strengths of 0.005% calcipotriene and 0.064% betamethasone dipropionate. The net weight is 60 grams. The label includes dosage and storage instructions and is distributed by EPI Health, LLC and manufactured for MC2 Therapeutics Ltd.*
FDA Label Image

Wynzora 04

Wynzora 04
Packaging label for Wynzora cream 0.005%/0.064% (calcipotriene and betamethasone dipropionate) topical cream. The label includes the proprietary and generic names, strength, usage instructions indicating it is for topical use only, and a net weight of 10 x 5 g samples marked as not for sale. It also lists inactive ingredients, storage instructions, distributor EPI Health LLC (Charleston, SC), and manufacturer MC2 Therapeutics Ltd (Guildford, UK). The design features a teal and white color scheme with a distinctive logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.